US 10322094
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted A61KA61K31/047A61K31/135
Quick answer
US patent 10322094 (Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride) held by TONIX PHARMA LIMITED expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TONIX PHARMA LIMITED
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/047, A61K31/135, A61K31/137, A61K31/55